BryanLawrenceOhningMD

PubMed

• 2 citations
  Enhancing team success in the neonatal intensive care unit: challenges and opportunities for fluid teams.
  Elizabeth A Bell, Gabrielle A Rufrano, Allison M Traylor, Eduardo Salas, Ohning, B.> ;Frontiers in Psychology. 2023 Jan 1
• 6 citations
  Effects of changing health care financial policy on very low birthweight neonatal outcomes.
  Karen J. Lessaris, David J. Annibale, W. Michael Southgate, Thomas C. Hulsey, Bryan L. Ohning> ;Southern Medical Journal. 2002 Apr 1
• 37 citations
  Randomized, controlled trial of nasopharyngeal continuous positive airway pressure in the extubation of very low birth weight infants
  David J. Annibale, Thomas C. Hulsey, Paul C. Engstrom, Lawrence A. Wallin, Bryan L. Ohning> ;The Journal of Pediatrics. 1994 Mar 1
• 13 citations
  Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia
  Bryan L. Ohning, Derek A. Fyfe, Philip A. Riedel> ;American Heart Journal. 1993 Jan 1
• 14 citations
  The disposition of alfentanil in neonates with respiratory distress.
  Donald B. Wiest, Bryan L. Ohning, Sandra S. Garner> ;Pharmacotherapy. 1991 Jul 8
• 75 citations
  Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
  Robert H. Notter, Donald L. Shapiro, B. Ohning, Jeffrey A. Whitsett> ;Chemistry and Physics of Lipids. 1987 Jun 1
• 29 citations
  Structural relationships of the major glycoproteins from human alveolar proteinosis surfactant.
  Gary Ross, Bryan Ohning, David Tannenbaum, Jeffrey A. Whitsett> ;Biochimica Et Biophysica Acta. 1987 Feb 25
• 66 citations
  Immunologic identification of a pulmonary surfactant-associated protein of molecular weight = 6000 daltons.
  Jeffrey A. Whitsett, William M. Hull, Bryan Ohning, Gary Ross, Timothy E. Weaver> ;Pediatric Research. 1986 Aug 1
• 181 citations
  Hydrophobic Surfactant-Associated Protein in Whole Lung Surfactant and Its Importance for Biophysical Activity in Lung Surfactant Extracts Used for Replacement Therapy
  Jeffrey A. Whitsett, Bryan L. Ohning, Gary F. Ross, Meuth Joseph L, Timothy E. Weaver, Brijce A. Holm, Donald L. Shapiro, Robert H. Notter> ;Pediatric Research. 1986 May 1
• 36 citations
  Purification of canine surfactant-associated glycoproteins A. Identification of a collagenase-resistant domain.
  Gary Ross, Joe Meuth, Bryan Ohning, Yangkil Kim, Jeffrey A. Whitsett> ;Biochimica Et Biophysica Acta. 1986 Mar 28
• 1 citations
  Ticarcillin-associated granulocytopenia.
  Bryan L. Ohning, Michael D. Reed, Carl F. Doershuk, Jeffrey L. Blumer> ;American Journal of Diseases of Children. 1982 Jul 1
• Neonatal pharmacodynamics--basic principles. I: Drug delivery.
  Ohning, B. L.> ;Neonatal Netw. 1995 Mar
• Neonatal pharmacodynamics--basic principles. II: Drug action and elimination.
  Ohning, B. L.> ;Neonatal Netw. 1995 Mar
• Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn.
  Washington, E. C., Ector, W., Abboud, M., Ohning, B., Holden, K.> ;South Med J. 1995 Jul
• Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication.
  Ohning, B. L., Reed, M. D., Blumer, J. L.> ;Pediatr Pharmacol (New York). 1986 Jan 01
• Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B.
  Sarin, V. K., Gupta, S., Leung, T. K., Taylor, V. E., Ohning, B. L., Whitsett, J. A., Fox, J. L.> ;Proc Natl Acad Sci U S A. 1990 Apr
• Join now to see all